856 Participants Needed

Mobile Monitoring for Postoperative Complications

(COSMOS Trial)

DI
LH
Overseen ByLisa Humbert, MBA
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: The Cleveland Clinic
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 2 JurisdictionsThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a new method for monitoring patients after major non-cardiac surgeries. It uses the GE Portrait Mobile Monitoring Solution, a mobile system, to track vital signs and determine if it can detect problems earlier. The trial includes two groups: one where the medical team accesses the monitoring data and another where they do not. It seeks participants planning to undergo major surgery lasting over 1.5 hours with an overnight hospital stay. Participants should not have conditions that complicate monitoring, such as significant hearing or vision problems.

As a Phase 2 trial, this research measures the effectiveness of the monitoring solution in an initial, smaller group, allowing participants to contribute to innovative healthcare solutions.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.

What prior data suggests that the GE Portrait Mobile Monitoring Solution is safe for postoperative patients?

Research has shown that the GE Portrait Mobile Monitoring Solution is safe and easy for patients to use. A previous study found that this system effectively tracks changes in vital signs without causing harm. It provides real-time alerts about a patient's condition, reducing the risk of complications after surgery.

The device is wireless and wearable, offering convenience for patients. Studies have not reported any negative effects directly linked to this monitoring solution, suggesting it is safe for patients recovering from surgery. The device aims to improve patient outcomes by closely monitoring vital signs like breathing rate and oxygen levels, enabling healthcare providers to respond quickly if any issues arise.

Overall, the available safety data supports using the GE Portrait Mobile Monitoring Solution as a reliable tool for post-surgery care.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores the potential of continuous postoperative vital sign monitoring using the GE Portrait Mobile Monitoring Solution. Unlike traditional intermittent monitoring, this mobile solution offers constant, real-time data, which may help in early detection of complications after surgery. The trial includes two unique approaches: blinded monitoring, where data is hidden from clinicians, and unblinded monitoring, where data is visible to healthcare providers. Understanding the impact of continuous monitoring could lead to significant improvements in patient outcomes by allowing for quicker interventions and more personalized care.

What evidence suggests that the GE Portrait Mobile Monitoring Solution is effective for reducing vital sign abnormalities in postoperative patients?

Research has shown that the GE Portrait Mobile Monitoring Solution helps reduce unusual vital signs in patients recovering from major surgeries. In this trial, participants will be assigned to either a blinded or unblinded monitoring arm using this device. A small study found that continuous monitoring with this device lowered these abnormalities by 25%. Additionally, 82% of the alarms from the device proved helpful, prompting quick responses from healthcare staff. This indicates that the device can improve patient care by alerting nurses to important changes in a patient's condition. Overall, the evidence supports that this monitoring solution enhances care after surgery.13678

Who Is on the Research Team?

Daniel I. Sessler, M.D.- Outcomes ...

Daniel Sessler, MD

Principal Investigator

The Cleveland Clinic

Are You a Good Fit for This Trial?

This trial is for adults over 18 who are recovering from major noncardiac surgery that lasted at least 1.5 hours, will stay in the hospital overnight, and had general or neuraxial anesthesia. They should be in a physical condition rated between 1-4 by the American Society of Anesthesiologists.

Inclusion Criteria

Expected to be admitted to one of the wards equipped with the GE Portrait Mobile Monitoring Solution
My overall health is good enough for surgery.
I am scheduled for a major surgery that will last at least 1.5 hours.
See 2 more

Exclusion Criteria

Expected to have telemetry monitoring
Have previously participated in the study
I am under end-of-life care plans like Do Not Resuscitate or hospice.
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Unblinded continuous ward monitoring with the GE Portrait Mobile Monitoring Solution and nursing alerts to reduce vital sign abnormalities during the initial 48 postoperative hours

48 hours
Continuous monitoring during hospital stay

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • GE Portrait Mobile Monitoring Solution
Trial Overview The COSMOS Trial is testing if continuous monitoring with GE Portrait Mobile Monitoring Solution and nurse alerts can reduce post-surgery vital sign abnormalities compared to standard care without constant monitoring.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Group I: Unblinded monitoringExperimental Treatment1 Intervention
Group II: Blinded monitoringExperimental Treatment1 Intervention

GE Portrait Mobile Monitoring Solution is already approved in European Union, United States for the following indications:

🇪🇺
Approved in European Union as Portrait Mobile for:
🇺🇸
Approved in United States as Portrait Mobile for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

The Cleveland Clinic

Lead Sponsor

Trials
1,072
Recruited
1,377,000+

Published Research Related to This Trial

A scoping review of 34 studies on patient-generated health data (PGHD) for monitoring surgical site infections (SSI) revealed that while patient satisfaction was commonly measured, only a few studies involved patients in developing PGHD tools.
Interviews with 24 stakeholders highlighted the critical need for patient involvement in designing mHealth interventions, emphasizing that incorporating patient perspectives can enhance the effectiveness and acceptance of these technologies in post-operative care.
Engaging Patients in Co-Design of Mobile Health Tools for Surgical Site Infection Surveillance: Implications for Research and Implementation.Lavallee, DC., Lee, JR., Semple, JL., et al.[2020]
A study involving 27 postoperative patients demonstrated that monitoring wound healing through smartphone-captured photographs sent via WhatsApp is feasible and effective, with 100% accuracy in detecting complications.
The method was well-received, with 81% of patients expressing satisfaction, suggesting that remote photographic assessments could reduce the need for in-person follow-ups and ease the burden on healthcare facilities.
Smartphone photography for smart assessment of post-surgical wounds - an experience during the COVID-19 pandemic.Salati, SA.[2022]
A study involving 65 patients showed that using a mobile app for post-operative monitoring was feasible, with high patient engagement as evidenced by an average of 23.9 logins for breast surgery patients and 19.3 for orthopedic patients over 30 days.
Both patients and surgeons reported high satisfaction with the mobile app, scoring it around 3.9 and 3.7 out of 4, indicating that the app effectively facilitated monitoring and could improve post-operative care efficiency.
Using a mobile app for monitoring post-operative quality of recovery of patients at home: a feasibility study.Semple, JL., Sharpe, S., Murnaghan, ML., et al.[2022]

Citations

Pilot Study Showcases the Value of Portrait Mobile ...The study showed 82% of Portrait Mobile alarms were informative, leading to more oxygen use, reduced vital sign abnormalities, and less than 3 ...
GE HealthCare's Pilot Study Shows Value of Portrait MobileA pilot study from GE Healthcare has shown the value of Portrait Mobile Continuous Monitoring Solution, a leap in post-surgical monitoring efficiency.
Pilot Study Showcases the Value of Portrait Mobile ...The results from this study highlight the potential of the wireless and wearable Portrait Mobile monitoring solution to provide meaningful ...
GE HealthCare reports results from Portrait Mobile pilot studyOverall, continuous monitoring and alerts with Portrait Mobile led to around 25% reduction in vital sign abnormalities. Following the completion ...
GE HealthCare study finds wearable monitors effectiveThe study revealed that in the Portrait Mobile group, clinicians encountered less than three alarms per patient per day, with 82% of those ...
Mobile Monitoring for Postoperative ComplicationsThe GE Portrait Mobile Monitoring Solution is unique because it uses mobile technology to continuously monitor patients' vital signs and detect complications in ...
PORTRAIT™ MOBILEContinuous monitoring can help drive better outcomes by helping increase patient safety and minimizing costs incurred from preventable adverse events.1 Because ...
Portrait Mobile Wireless Monitoring Solution, USThe Portrait Mobile platform enables real-time continuous monitoring of patient vitals such as respiration rate, oxygen saturation, and pulse ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security